Swedish Orphan Biovitrum AB (0MTD:LSE) Annual Income Statement ()
0MTD:LSE Quarterly Financials ()
Frequently Asked Questions About Swedish Orphan Biovitrum AB (0MTD:LSE) Stock
Swedish Orphan Biovitrum AB's (0MTD:LSE) last reported annual revenue was N/A.
Swedish Orphan Biovitrum AB's (0MTD:LSE) annual revenue growth rate based on the revenue reported in the past 5 years is : N/A
Swedish Orphan Biovitrum AB's(0MTD:LSE) is not profitable as of its last reported annual financials.
The net profit margin for Swedish Orphan Biovitrum AB's(0MTD:LSE) from its laster reported year is N/A
The return on equity (ROE) for Swedish Orphan Biovitrum AB's(0MTD:LSE) from its last reported annual financials is : 7.98%
The return on assets (ROA) for Swedish Orphan Biovitrum AB's(0MTD:LSE) from its last reported annual financials is : 4.61%
The return on invested capital (ROIC) for Swedish Orphan Biovitrum AB's(0MTD:LSE) from its last reported annual financials is : 0.00%
The Debt to Equity ratio for Swedish Orphan Biovitrum AB's(0MTD:LSE) from its last reported annual financials is : 0.00%
The dividend yield for Swedish Orphan Biovitrum AB's(0MTD:LSE) from its laster reported year is 0.00%
Swedish Orphan Biovitrum AB's(0MTD:LSE) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
There is nothing we particularly dislike
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for 0MTD:LSE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
